Effects of 5/6 nephrectomy on renal function and blood pressure in mice

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 4, Issue 3, 2012, Pages 167-173

  Gava, Agata L ^a   Freitas, Flavia P S ^a   Balarini, Camille M ^a   Vasquez, Elisardo C ^a,b   Meyrelles, Silvana S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

5 6 nephrectomy; Chronic kidney disease; Mice; Renal function

Indexed keywords

CALCIUM; COLLAGEN; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CALCIUM EXCRETION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; FLUID INTAKE; FOOD INTAKE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HISTOLOGY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; MESANGIUM CELL; MOUSE; NEPHRECTOMY; NONHUMAN; POTASSIUM EXCRETION; PROTEINURIA; SODIUM EXCRETION; UREMIA; URINALYSIS; URINARY EXCRETION; URINE VOLUME;

EID: 84867037792     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: final data for 2003. Natl Vital Stat Rep 2006; 54: 1-120.
2. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 830-837.
3. Islam TM, Fox CS, Mann D, Muntner P. Agerelated associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol 2009; 10: 17.
4. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14: 2084-2091.
5. Kang DH, Nakagawa T, Feng L, Johnson RJ. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 2002; 161: 239-248.
6. Santos LS, Chin EW, Ioshii SO, Tambara Filho R. Surgical reduction of the renal mass in rats: morphologic and functional analysis on the remnant kidney. Acta Cir Bras 2006; 21: 252-257.
7. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 1999; 56: 333-337.
8. Fujihara CK, Malheiros DM, Zatz R. Losartanhydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. Am J Physiol Renal Physiol 2007; 292: F1810-1818.
9. Terzi F, Burtin M, Hekmati M, Jouanneau C, Beaufils H, Friedlander G. Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions. Exp Nephrol 2000; 8: 104-114.
10. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G. Effect of renin-angiotensinaldosterone system inhibition, dietary sodium estriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009; 53: 16-25.
11. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 2003; 64: 350-355.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
13. Rostoker G, Andrivet P, Pham I, Griuncelli M, Adnot S. Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies. BMC Nephrol 2009; 10: 16.
14. Shara NM, Resnick HE, Lu L, Xu J, Vupputuri S, Howard BV, Umans JG. Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J Nephrol 2009; 22: 373-380.
15. Gagnon RF, Duguid WP. A reproducible model for chronic renal failure in the mouse. Urol Res 1983; 11: 11-14.
16. Gagnon RF, Gallimore B. Characterization of a mouse model of chronic uremia. Urol Res 1988; 16: 119-126.
17. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein Edeficient mice. J Am Soc Nephrol 2003; 14: 2466-2474.
18. Pickering JW, Frampton CM, Walker RJ, Shaw GM, Endre ZH. Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients. Crit Care 2012; 16: R107.
19. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectinknockout mice. Arterioscler Thromb Vasc Biol 2007; 27: 1910-1917.
20. Bro S, Bollano E, Brüel A, Olgaard K, Nielsen LB. Cardiac structure and function in a mouse model of uraemia without hypertension. Scand J Clin Lab Invest 2008; 68: 660-666.
21. Gagnon RF, Ansari M. Development and progression of uremic changes in the mouse with surgically induced renal failure. Nephron 1990; 54: 70-76.
22. Maizel J, Six I, Slama M, Tribouilloy C, Sevestre H, Poirot S, Giummelly P, Atkinson J, Choukroun G, Andrejak M, Kamel S, Mazière JC, Massy ZA. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation 2009; 119: 306-313.
23. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456.
24. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 2006; 17: S98-103.
25. Ghosh SS, Krieg RJ, Sica DA, Wang R, Fakhry I, Gehr T. Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol 2009; 24: 367-377.
26. Podjarny E, Bernheim J, Hasdan G, Karsh D, Rashid G, Green J, Katz B, Bernheim J. Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy. Nephrol Dial Transplant 2007; 22: 1864-1872.
27. Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, Maruyama S, Ito Y, Kobori H, Ikematsu S, Nishiyama A, Matsuo S, Kadomatsu K. The growth factor midkine regulates the reninangiotensin system in mice. J Clin Invest 2009; 119: 1616-1625.
28. Campese VM, Mozayeni P, Ye S, Gumbard M. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure. J Nephrol 2002; 15: 407-413.
29. Chatziantoniou C, Boffa JJ, Tharaux PL, Flamant M, Ronco P, Dussaule JC. Progression and regression in renal vascular and glomerular fibrosis. Int J Exp Pathol 2004; 85: 1-11.
30. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608.
31. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762.
32. Kwon TH, Frøkiaer J, Fernández-Llama P, Maunsbach AB, Knepper MA, Nielsen S. Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys. Am J Physiol 1999; 277: F257-270.
33. Kim EJ, Jung YW, Kwon TH. Angiotensin II AT1 receptor blockade changes expression of renal sodium transporters in rats with chronic renal failure. J Korean Med Sci 2005; 20: 248-255.
34. Hruska KA, Saab G, Mathew S, Lund R. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 2007; 20: 309-315.